
Rejunuron PL 750mcg/75mg Tablet SR
Marketer
Fourrts India Laboratories Pvt Ltd
Salt Composition
Methylcobalamin (750mcg) + Pregabalin (75mg)
Overview Rejunuron PL 750mcg/75mg Tablet SR
Neuropain-750 SR tablets (750mcg/75mg) are a prescription medication for neuropathic pain management. Its mechanism involves modulating nerve cell calcium channel activity to reduce pain signals. This medication also supports nerve fiber health and promotes nerve cell repair. Neuropain-750 SR is administered orally, with or without food, ideally before sleep. Consistent daily dosing maintains therapeutic levels. Follow your doctor's prescribed dosage and duration, as this medication can be habit-forming. If a dose is missed, take it upon recollection. Complete the entire treatment course, even with symptom improvement. Abrupt cessation requires prior medical consultation. Common side effects may include upper respiratory infection, increased hunger, elevated mood, trembling, vision blurring, dry mouth, lightheadedness, and drowsiness. Avoid activities requiring alertness until the medication's effects are understood. Side effects are generally mild and often subside. Weight gain is possible; regular exercise and a balanced diet can help mitigate this. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal ideation to your physician. Disclose all other medications to your doctor, as interactions may reduce efficacy or alter the medication's action. Inform your doctor of pregnancy, pregnancy plans, or breastfeeding.
Primary Ingredients of Rejunuron PL 750mcg/75mg Tablet SR
There is no text provided to rephrase.
Uses of Rejunuron PL 750mcg/75mg Tablet SR
Managing neuropathic pain
Major Benefits of Rejunuron PL 750mcg/75mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Rejunuron PL 750mcg/75mg Sustained-Release Tablet can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Rejunuron PL 750mcg/75mg Tablet SR:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use Rejunuron PL 750mcg/75mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Rejunuron PL 750mcg/75mg Sustained-Release Tablet can be consumed with or without food, though consistent timing is recommended.
How Rejunuron PL 750mcg/75mg Tablet SR works:
Rejunuron PL 750mcg/75mg Extended-Release Tablets combine methylcobalamin, a vitamin B12 variant, with pregabalin, an alpha-2-delta ligand. Methylcobalamin supports myelin sheath production, protecting and repairing nerve cells. Pregabalin reduces pain by modifying calcium channel function in nerve cells. This dual action provides effective relief from the discomfort of neuropathic pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Rejunuron PL 750mcg/75mg sustained-release tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Rejunuron PL 750mcg/75mg Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against possible dangers prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Rejunuron PL 750mcg/75mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Rejunuron PL 750mcg/75mg Extended-Release tablets might cause drowsiness, blurred vision, or dizziness. Refrain from operating a vehicle if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Rejunuron PL 750mcg/75mg Tablet SR cautiously, potentially requiring a modified dosage. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Use of Rejunuron PL 750mcg/75mg Tablet SR in patients with liver disease appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary for this patient group. However, physician consultation is recommended.
What if you forget to take Rejunuron PL 750mcg/75mg Tablet SR :
Should you forget a Rejunuron PL 750mcg/75mg Tablet SR dose, ingest it immediately if feasible. Otherwise, near the time for your next scheduled dose, omit the missed one and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Rejunuron PL 750mcg/75mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
